Tendons are specialised collagenous tissues that transmit muscle force to bone with minimal elasticity—a design that makes them prone to partial tears and degeneration when overstressed.
Tendons are specialised collagenous tissues that transmit muscle force to bone with minimal elasticity—a design that makes them prone to partial tears and degeneration when overstressed. Unlike muscle, tendons have poor intrinsic healing capacity due to limited blood supply and sparse resident cell populations. Recovery from tendon injury often stalls at a fibrotic scar that is weaker and less organised than native tissue. Cell therapy approaches employ placental MSCs, exosomes (acellular vesicles carrying molecular signals), and sometimes engineered chondrocytes to promote tissue remodelling and fibril alignment. The proposed mechanism involves delivering cells or their secreted factors directly to the injury site, where they are thought to reduce inflammation, promote angiogenesis (new blood vessel formation), and guide collagen deposition along physiologically correct orientations.
| Indikative Kosten · Bulgarien (EU) | €3,000–€8,000 |
|---|---|
| Globale Marktkostenfalle | €3,680–€9,200 (dvcstem.com) |
| Wichtigste untersuchte Zelltypen | MSCs from Amniotic Membrane, Exosomes, Chondrocytes |
| Genehmigungsstatus | Experimentell |
| Registrierte Studien (ClinicalTrials.gov) | 22 · 1 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
The tendon-injury cell-therapy landscape encompasses 22 completed trials and 1 actively recruiting study. Most involve placental MSC injections or exosome preparations administered directly into the tendon lesion under ultrasound guidance. Trial cohorts typically include both acute partial tears and chronic degenerative tendinopathy. Imaging outcomes (ultrasound, MRI) in small studies show improved fibre continuity and reduced fluid signal in approximately 50–70% of treated tendons. Functional metrics (strength, pain reduction, return-to-activity) vary by trial; some report 60–80% of athletes returning to sport within 6–12 months, though untreated controls are rarely present for comparison.
Depending on assessment, a Tendon & Sports Injuries protocol may draw on:
Tendon-directed cell therapy costs €3,500–6,500 per session, reflecting the technical demand of ultrasound-guided injection, cell preparation, and quality assurance. Imaging—baseline and follow-up ultrasound or MRI—adds €600–1,500. Participants intending to return to elite sport often pursue two or three injections spaced 6–8 weeks apart, bringing total cost to €10,000–18,000; many centres recommend 6- and 12-month follow-up imaging.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Tendon & Sports Injuries cost-by-country breakdown, or compare the best countries for Tendon & Sports Injuries →
Vor der Buchung prüfen: Sicherheit & Regulierung, das Erholungsklima, ob Sie geeignet sind, und welcher Zelltyp zu Tendon & Sports Injuries passt.
Vollständiges Sehnen- und Sportverletzungen FAQ → · Sehnen- und Sportverletzungen Kostenaufschlüsselung →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Bin ich geeignet? · Welcher Zelltyp? · Types of clinics & best countries · Kostenrechner
Medizinisch geprüft vom Redaktionsteam von StemCellAtlas zusammen mit Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) der Partnerklinik Stem Plus (Sofia), gemäß ISSCR-, FDA- und EMA-Leitlinien. Educational information, not medical advice; figures indicative.
GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.
Kostenlose ärztliche Prüfung